AARDEX still confirms its leading position in the B2B medication adherence market, closing steadily more new deals with Pharma Companies, Biotech’s, Excellence Centers and Universities, over 30 countries in 2018.
Breaking News
New trial protocol guidance: Updated in SPIRIT but falling short on adherence
In the early stages of drug development, as the promise surrounding a new therapy builds, there is a palpable sense of the stakes being raised. And when encouraging findings lead to progress on the clinical trial pathway, those stakes are
Oksana Pidmogylna
June 19, 2025
